ELV

SEC source: 0001156039-23-000026 · wf-form4_167787821928724.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,646

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.

SEC source: 0001156039-23-000026 · wf-form4_167787821928724.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & CarelonRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,354

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · derivative · entry 5

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,782

Underlying: Common Stock · 11,782 shares

Expires 2033-03-01

F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 3

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,375

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023.

SEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 2

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,659

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.

SEC source: 0001156039-23-000025 · wf-form4_167787809281315.xml · nonDerivative · entry 1

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,594

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-23-000024 · wf-form4_167787796641640.xml · derivative · entry 6

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,380

Underlying: Common Stock · 32,380 shares

Expires 2033-03-01

F5 · derivative.exercise_date: The option represents a right to purchase a total of 32,380 shares, and is exercisable in two installments of 10,793 shares each and one installment of 10,794 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.

SEC source: 0001156039-23-000024 · wf-form4_167787796641640.xml · nonDerivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,477

F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2023.

SEC source: 0001156039-23-000024 · wf-form4_167787796641640.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,602

F2 · shares: Represents restricted share units. Restrictions lapse as follows: 2,807 shares each on 3/1/2024 and 3/1/2025 and 2,808 shares on 3/1/2026.

SEC source: 0001156039-23-000024 · wf-form4_167787796641640.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,180

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-23-000004 · wf-form4_167295620591732.xml · nonDerivative · entry 1

Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,283

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 1,327 shares on 1/3/2024, and 1,328 shares each on 1/3/2025 and 1/3/2026.

SEC source: 0001156039-23-000002 · wf-form4_167286901422962.xml · nonDerivative · entry 1

Norwood Felicia F · CIK 0001743548 · EVP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,684

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-22-000096 · wf-form4_167027719877040.xml · nonDerivative · entry 1

Todt Blair Williams · CIK 0001456430 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,300

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-22-000094 · wf-form4_166759592352354.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,415

F1 · balance_after: Balance includes 252.31 shares acquired on March 25, 2022, 257.62 shares acquired on June 24, 2022 and 266.45 shares acquired on September 23, 2022 through a dividend reinvestment plan.

SEC source: 0001156039-22-000090 · wf-form4_166742418792208.xml · nonDerivative · entry 1

STRABLE-SOETHOUT DEANNA D · CIK 0001278726 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · shares: Phantom Stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of the annual meeting of shareholders that immediately precedes the Director's election date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000092 · wf-form4_166750970556244.xml · nonDerivative · entry 1

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,450

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-22-000091 · wf-form4_166750960915281.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & Pres Carelon & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,961

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · derivative · entry 13

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common Stock · 987 shares

Expires 2031-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option represents a right to purchase a total of 2,963 shares, and is exercisable in three annual installments, with one installment of 987 shares and two installments of 988 shares each, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · derivative · entry 12

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 568 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option represents a right to purchase a total of 3,404 shares, and is exercisable in six semi-annual installments, with four installments of 567 shares each and two installments of 568 shares each beginning on 9/01/2018, which is the six-month anniversary of the date on which the option was granted.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · derivative · entry 11

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,387

Underlying: Common Stock · 2,774 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option represents a right to purchase a total of 4,161 shares, and is exercisable in three annual installments of 1,387 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · derivative · entry 10

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,999 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option represents a right to purchase a total of 2,997 shares, and is exercisable in three annual installments, with one installment of 998 shares, one installment of 999 shares and one installment of 1,000 shares, beginning on 3/1/2020, which is the one-year anniversary of the option grant date.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 9

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,529

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 8

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,735

F4 · price: This transaction was executed in multiple trades at prices ranging from $490.37 to $491.33. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 7

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,257

F3 · price: This transaction was executed in multiple trades at prices ranging from $489.19 to $489.83. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 6

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,041

F2 · price: This transaction was executed in multiple trades at prices ranging from $488.19 to $489.18. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 5

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,657

F1 · price: This transaction was executed in multiple trades at prices ranging from $487.13 to $487.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 4

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 3

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 2

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001156039-22-000073 · wf-form4_165515231669369.xml · nonDerivative · entry 1

Kendrick Charles Morgan JR · CIK 0001887908 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001156039-22-000071 · wf-form4_165463499095953.xml · nonDerivative · entry 1

Dixon Robert L JR · CIK 0001524849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,491

SEC source: 0001156039-22-000066 · wf-form4_165307975417679.xml · nonDerivative · entry 2

PERU RAMIRO G · CIK 0001192045 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,405

F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

SEC source: 0001156039-22-000068 · wf-form4_165307980598753.xml · nonDerivative · entry 1

DeVore Susan D. · CIK 0001587697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 856

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000069 · wf-form4_165307983878223.xml · nonDerivative · entry 1

Neri Antonio F · CIK 0001648401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,479

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000067 · wf-form4_165307978079045.xml · nonDerivative · entry 1

HAY LEWIS III · CIK 0001182705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,061

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000066 · wf-form4_165307975417679.xml · nonDerivative · entry 1

PERU RAMIRO G · CIK 0001192045 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,395

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000065 · wf-form4_165307972769440.xml · nonDerivative · entry 1

CLARK R KERRY · CIK 0001180776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,194

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000064 · wf-form4_165307970610208.xml · nonDerivative · entry 1

Tallett Elizabeth E · CIK 0001192460 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,446

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000063 · wf-form4_165307968805222.xml · nonDerivative · entry 1

Schneider Ryan M. · CIK 0001420501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,154

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000062 · wf-form4_165307967082290.xml · nonDerivative · entry 1

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,342

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000061 · wf-form4_165307965341824.xml · nonDerivative · entry 1

Dixon Robert L JR · CIK 0001524849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,911

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · derivative · entry 8

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,848 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option represents a right to purchase a total of 24,348 shares and is exercisable in six semi-annual installments, with six installments of 4,058 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 7

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,161

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 6

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,201

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

F6 · price: This transaction was executed in multiple trades at prices ranging from $462.34 to $463.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 5

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

F5 · price: This transaction was executed in multiple trades at prices ranging from $461.27 to $462.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 4

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,315

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

F4 · price: This transaction was executed in multiple trades at prices ranging from $460.26 to $461.19. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 3

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,420

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $459.25 to $460.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,694

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $458.18 to $459.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001156039-22-000040 · wf-form4_164729006481345.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & Pres., DBG & IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001156039-22-000025 · wf-form4_164634874872945.xml · derivative · entry 12

Penczek Ronald W · CIK 0001659075 · CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 468 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option represents a right to purchase a total of 1,403 shares, and is exercisable in three annual installments, with one installment of 467 shares and two installments of 468 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date.